Poxel SA (LTS:0RA2)
€ 0.1424 0 (0%) Market Cap: 7.53 Mil Enterprise Value: 52.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 8/100

Poxel SA - Special Call Transcript

Apr 09, 2019 / 12:30PM GMT
Release Date Price: €8.94 (+5.33%)
Operator

Ladies and gentlemen, welcome to the Poxel Conference Call. I now hand call over to Jonae Barnes. Madam, please go ahead.

Jonae R. Barnes
Poxel SA - SVP of IR & Public Relations

Thank you for joining us today. With me on the call are Thomas Kuhn , CEO; Christophe Arbet-Engels, Chief Medical Officer and EVP Late Development and Medical Affairs; Pascale Fouqueray, EVP of Early Development and Translational Medicine; and Renevot, our Chief Financial Officer; and Noah Beerman, President of U.S. Operations and Executive Vice President of Business Development. Before we begin, I would like to read our forward-looking statement. Some of the statements contained in this presentation constitute forward-looking statements, which are statements that are not historical facts. These statements are based on the company's current strategy, plans, objectives, assumptions, estimates and projections. Investors should, therefore, not place undue reliance on these statements.

The company makes no representation, warranty or prediction that the results anticipated by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot